ESSA Pharma Inc. (NASDAQ: EPIX) was founded in 2009 and is headquartered in Vancouver, Canada, with 15 full-time employees. It is a clinical-stage pharmaceutical company focused on the development of new therapies for the treatment of prostate cancer.
ESSA Pharma Inc. (EPIX):
ESSA Pharma is developing EPI-506, which is currently in phase I/II clinical trials for the treatment of prostate cancer.
The company has less public information. If you want to invest in the company, you can visit the official website through the link below to find some clues.